Type 2 diabetes is the most common type of diabetes. And, while a healthy diet can help in managing the disease, there is also a beverage that is suited for diabetics.
Blood glucose or blood sugar coming from the food you eat is your body's main source of energy. In response to the presence of glucose, your pancreas makes the hormone insulin, which helps the glucose get into your cells to be used as energy.
Diabetes happens when your body either cannot produce enough insulin, or it cannot use insulin properly.
In type 2 diabetes, your pancreas is not able to make enough insulin that is required because your body has become resistant to its effect. Thus, the glucose builds up in your blood.
If you have type 2 diabetes, it is important for you to be careful about what you eat aside from taking medication.
You have to make sure that your blood glucose will not spike, or it will stay high for a long period of time to avoid more complications in your health.
Not only should you be careful about what you eat, but you should also be careful about what you drink.
According to the Daily Express, one of the best drinks that a diabetic patient can take is water.
Drinking lots of water all throughout the day will keep your blood hydrated when the body attempts to get rid of the excess glucose through the urine.
If you are not drinking enough water, your body will not be able to remove excess glucose through your urine, and this will lead to further dehydration.
Water does not contain any calories, so it is safe for diabetic patients to drink plenty of it all day.
According to a study, water will not increase the level of glucose in the blood. The study further found out that when a person's glucose level is too high, the excess glucose will be flushed out of the bloodstream by drinking more water.
Thus, that is why health experts recommend water as the best beverage for type 2 diabetic patients.
Image credit courtesy of Enid Martindale/Flickr


Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



